51吃瓜黑料曝料

Study Name Principal Investigator
(ALPINE2) Randomized, Double-Blind, Phase 3B Trial to Evaluate the Safety and Efficacy of 2 Treatment Regimens of Aztreonam 75 mg Powder and Solvent for Nebulizer Solution / Aztreonam for Inhalation Solution (AZLI) in Pediatric Subjects with Cystic Fibrosis (CF) and New Onset Respiratory Tract Pseudomonas aeruginosa (PA) Infection/Colonization [Aztreonam Lysine for Pseudomonas INfection Eradication 2 (ALPINE 2) Study] McKie, Kathleen
(CD12) A Phase 2b/3, Randomized, Double Blind, Placebo Controlled, Adaptive Design Study to Evaluate the Efficacy and Safety of Leronlimab for Patients with Severe or Critical Coronavirus Disease 2019 (COVID-19) Islam, Shaheen
(EB05) A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Eb05 + SOC vs. Placebo + SOC in Adult Hospitalized Patients with Covid-19 Taskar, Varsha
(EUROPA) Expanded Use of Remote Objective Monitoring During Telehealth Visits for People with CF Experiencing Acute Symptoms (Project EUROPA) Forseen, Caralee
(INS-416) ENCORE - A Randomized, Double-Blind, Placebo-Controlled, Active Comparator, Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC) Taskar, Varsha
(Inspire Adhere) Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry Groves, Michael
(MEDLEY) A Phase 2/3 Randomized, Double-blind, Palivizumab-controlled Study to Evaluate the Safety of MEDI8897, a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus, in High-risk Children Patel, Pinkal
(Reach-OB-23) A Research Study to Advance the CF Therapeutics Pipeline for People without Modulators Forseen, Caralee
(Verona Pharma) A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Ensifentrine in Subjects with Non-Cystic Fibrosis Bronchiectasis Taskar, Varsha
Facial Recognition Software to Identify Facial Features that Predict Difficulty of Mask Ventilation and Intubation. Rocuts Martinez, Klifford
Georgia CF Center Longitudinal Phenotyping (CFP30-P) Harris, Ryan
MORAb-202-G000-201: A Multicenter, Open-Label Phase 1/2 Trial Evaluating the Safety, Tolerability, and Efficacy of MORAb-202, a folate receptor alpha (FR?)-targeting antibody-drug conjugate (ADC) in Subjects With Selected Tumor Types Ghamande, Sharad
OASIS: A Phase III, adjudicator-blinded, randomised study to evaluate the efficacy and safety of treatment with olorofim versus treatment with AmBisome� followed by standard of care (SOC) in patients with invasive fungal disease (IFD) caused by Aspergillus species Huggett, Ashley
PILOT: Pilot for a Test-Negative Case-Control Study to Evaluate the Effectiveness of a New Adult Pneumococcal Vaccine Against Pneumococcal Pneumonia in Older Adults Vazquez, Jose
S1827, 揗RI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK)� Ghamande, Sharad
S1929, 揚hase II Randomized Study of Maintenance Atezolizumab versus Atezolizumab in Combination with Talazoparib in Patients with SLFN11 Positive Extensive Stage Small Cell Lung Cancer (ES-SCLC)� Raval, Girindra
S1933, 揂 Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients with Borderline Performance Status� Raval, Girindra
The Effects of KT-Tape on Running Economy and Muscle Activation. Craig-Jones, Andrew
RESEARCH. INNOVATION. DISCOVERY.
51吃瓜黑料曝料
Research
AU Health
Stay Informed
Get updates on new trials and more
(706)721-6582 © 51吃瓜黑料曝料 1120 15th Street 51吃瓜黑料曝料, GA 30912